Organisation · Unternehmen
Innovative Medicines for Luxembourg ASBL
innovative-medicines-for-luxembourg-asbl-eutr-39786957
Aussagen (8)
eu transparency category
Trade and business associations
dokumentiert
[Q-21710]
eu transparency goals
The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in
Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation
and ensures that patients benefi t from the latest medical advances. Engaging with national and European stakeholders, IML advocates for policies that support pharmaceutical research, market access, and a strong healthcare ecosystem.
By facilitating dialogue between industry, policymakers, and healthcare professionals, IML contributes to shaping a
dynamic and innovation-driven pharmaceutical landscape in Luxembourg, ensuring sustainable access to cutting-edge
treatments.
Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation
and ensures that patients benefi t from the latest medical advances. Engaging with national and European stakeholders, IML advocates for policies that support pharmaceutical research, market access, and a strong healthcare ecosystem.
By facilitating dialogue between industry, policymakers, and healthcare professionals, IML contributes to shaping a
dynamic and innovation-driven pharmaceutical landscape in Luxembourg, ensuring sustainable access to cutting-edge
treatments.
dokumentiert
[Q-21710]
eu transparency id
430642397869-57
dokumentiert
[Q-7536]
headquarters city
Luxembourg
dokumentiert
[Q-21710]
headquarters country
LU
dokumentiert
[Q-21710]
interest class
business_association
dokumentiert
[Q-29773]
legal form
ASBL
dokumentiert
[Q-21710]
legal form class
ausland_sonstig
berichtet
[Q-29773]